Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

The discovery of a gut-to-brain regulation pathway in flies calls for additional consideration on how certain medications can be used to treat obesity and diabetes in humans.

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts ...

Weight loss jabs are not a “holy grail” and will not solve the obesity crisis on their own, England’s top doctor has said.

I don’t think suddenly we’ve got X amount of unemployed people and we all give them Mounjaro and once they start losing ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

We recently compiled a list titled Buffett Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we will look at ...

A woman from Burnham has called the government 'naïve' for suggesting weight-loss jabs would help unemployed people return to the workplace.

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Earlier this year, J.P. Morgan released a report outlining the potential for GLP-1 treatments in other markets. Specifically, ...